首页> 外文OA文献 >Real-world Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) for 8 weeks in Patients Coinfected with HCV and HIV-1

【2h】

Real-world Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) for 8 weeks in Patients Coinfected with HCV and HIV-1

机译：用HCV和HIV-1携带8周的LEDIPASVIR / SOFOSBUVIR（LDV / SOF）的现实世界效力

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Peter Ruane; Peter Buggisch; ANA Moreno; Vasily Isakov; Lisa Backus; Dani Ain; Juan Gonzalez-Garcia; Sarjita Naik; Swarup Mehta; Jina Lee; Joe Llewellyn; Michael Mertens; Macky Natha; Anu Osinusi; Jihad Slim; Konstantin Zhdanov; Juan Berenguer; Stefan Zeuzem;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Real World Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) in Patients Coinfected With HCV and HIV-1: A Comparative Analysis of Clinical Trials with Four Real World Cohorts [J] . Naggie Susanna, Rosenthal Eric, Kattakuzhy Sarah, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：HCV和HIV-1患者ledipasvir / sofosbuvir（LDV / SOF）的现实世界效力：四个现实世界队列的临床试验比较分析
2. Ledipasvir/Sofosbuvir plus Ribavirin (LDV/SOF+RBV) for 12 Weeks in Decompensated HCV Genotype 1 Patients: SOLAR-1 and-2 Studies Compared to a Real-World Dataset [J] . Charlton Michael R., Cheung Michelle C., Manns Michael P., Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：LEDIPASVIR / Sofosbuvir Plus Ribavirin（LDV / SOF + RBV）在失代偿的HCV基因型1名患者中持续12周：太阳能-1和-2研究与真实世界数据集相比
3. Real World Effectiveness of 8 vs 12 Weeks of Ledipasvir/Sofosbuvir (LDV/SOF) in Blacks with HCV: A Comparative Analysis of Clinical Trials with Real World Cohorts [J] . Wilson Eleanor, Davitkov Perica, Kwo Paul Y., Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：具有HCV的黑人ledipasvir / sofosbuvir（LDV / SOF）的8 vs 12周的现实效力：具有现实世界队列的临床试验的比较分析
4. The Use of Surrogate Markers to Predict Degree of Liver Damage in HIV/HCV Coinfected Patients [C] . S. Kimmel, M. Hoffman Terry International AIDS Conference . 2004

机译：使用替代标记以预测肝脏损伤患者肝损伤程度
5. Hepatitis C virus (HCV) replication in vitro and the effect of HCV on human immunodeficiency virus (HIV-1) coreceptor usage and diversity in the coinfected patient. [D] . Franco, Kelly Flory. 2007

机译：丙型肝炎病毒（HCV）的体外复制以及HCV对合并感染患者中人免疫缺陷病毒（HIV-1）共受体使用和多样性的影响。
6. Real-world Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) for 8 weeks in Patients Coinfected with HCV and HIV-1 [O] . Peter Ruane, Peter Buggisch, ANA Moreno, 2017

机译：Ledipasvir / Sofosbuvir（LDV / SOF）在HCV和HIV-1合并感染的患者中连续8周的实际效果
7. The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV) [O] . Pegah Golabi, Elzafir Elsheikh, Azza Karrar, 2016

机译：用ledipasvir（LDV）和Sofosbuvir（SOF）治疗的HCV患者单胺神经递质和心理和情绪健康措施的水平，或没有利韦韦林（RBV）

Real-world Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) for 8 weeks in Patients Coinfected with HCV and HIV-1

著录项

引文网络

相似文献

相关主题

期刊订阅